Prognostic significance and accuracy of oncologists' estimates of survival time in recurrent ovarian cancer.
Nahm SH, Kiely BE, O'Connell RL, Lee YC, Davis A, Avall-Lundqvist E, Berek JS, Berton D, Donnellan P, Hilpert F, Joly F, Lanceley A, Ledermann JA, Okamoto A, Oza A, Pignata S, Sehouli J, King MT, Friedlander M, Stockler MR, Roncolato FT; GCIG Symptom Benefit Group.
Nahm SH, et al. Among authors: okamoto a.
Int J Gynecol Cancer. 2025 Jan;35(1):100030. doi: 10.1016/j.ijgc.2024.100030. Epub 2024 Dec 18.
Int J Gynecol Cancer. 2025.
PMID: 39878283